miRNA	gene	miRNA_log2FC	miRNA_pvalue	gene_log2FC	gene_pvalue	interactions	correlation_beta	correlation_pvalue	PMID	evidence	outcome	cancer
hsa-let-7a-5p	E2F2	-0.0304750000000005	0.2544201287335	1.25491101439873	1.34486994652531e-12	miRNAWalker2_validate;miRTarBase;MirTarget;TargetScan	-1.97858164350895	9.28149482786318e-05	20418948;25647078	MicroRNA let 7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2;Tumor suppressive microRNA let 7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells; When let-7a was transfected into OS cell lines the expression of E2F2 in the cells was greatly suppressed suggesting that E2F2 is a target of miRNA-let-7a in OS cells	;	prostate cancer;sarcoma
hsa-let-7b-5p	E2F2	-0.118293750000001	0.000772100831422107	1.25491101439873	1.34486994652531e-12	MirTarget	-2.36608085838377	8.79191134852768e-11		NA	NA	NA
hsa-let-7c-5p	E2F2	-0.129896875000002	0.000858548240310724	1.25491101439873	1.34486994652531e-12	MirTarget	-2.72274215979195	6.74825903727559e-18		NA	NA	NA
hsa-let-7d-5p	E2F2	-0.00841145833333479	0.75459096821833	1.25491101439873	1.34486994652531e-12	MirTarget	-1.34108256638476	0.00845476863859243		NA	NA	NA
hsa-let-7e-5p	E2F2	-0.058575	0.0129021331137325	1.25491101439873	1.34486994652531e-12	MirTarget	-2.58353161693722	5.65668292323766e-06		NA	NA	NA
hsa-miR-125a-5p	E2F2	-0.127755208333335	0.000138704165746353	1.25491101439873	1.34486994652531e-12	MirTarget	-2.54853597252783	2.00342751711276e-11		NA	NA	NA
hsa-miR-125b-5p	E2F2	-0.187647916666668	1.01964050843717e-05	1.25491101439873	1.34486994652531e-12	miRNAWalker2_validate;miRTarBase;MirTarget;miRNATAP	-2.92521016860087	6.18507147456215e-27	22999819	miR 125b regulates the proliferation of glioblastoma stem cells by targeting E2F2; This study demonstrated that miR-125b plays important roles in regulating the proliferation of GSCs by directly targeting E2F2		glioblastoma
hsa-miR-130a-3p	E2F2	-0.191241666666667	4.92233337068236e-06	1.25491101439873	1.34486994652531e-12	miRNATAP	-1.56004095748561	4.27670534224481e-07		NA	NA	NA
hsa-miR-204-5p	E2F2	0.0144822916666668	0.790232989544289	1.25491101439873	1.34486994652531e-12	mirMAP	-1.08500357484495	9.5333500263092e-06		NA	NA	NA
hsa-miR-214-3p	E2F2	-0.3224875	1.46111391717269e-10	1.25491101439873	1.34486994652531e-12	mirMAP	-1.97230552740488	6.95908845269177e-17		NA	NA	NA
hsa-miR-22-3p	E2F2	-0.076525	0.0267118796232183	1.25491101439873	1.34486994652531e-12	miRNAWalker2_validate	-2.6735123134466	4.98412298162075e-13		NA	NA	NA
hsa-miR-26a-5p	E2F2	-0.0802614583333372	6.57714639384254e-05	1.25491101439873	1.34486994652531e-12	miRNATAP	-4.11998082781991	1.75389196865047e-10	26458859	MiR 26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2; Our results suggest that miR-26a can improve the sensitivity of GC cells to cisplatin-based chemotherapies through targeting NRAS and E2F2 and provide the first evidence of the potential utility of miR-26a as a sensitizer in chemotherapy for GC		gastric cancer
hsa-miR-26b-5p	E2F2	-0.0469791666666701	0.0492766500438207	1.25491101439873	1.34486994652531e-12	miRNATAP	-3.52479138620502	1.24264684304525e-10		NA	NA	NA
hsa-miR-373-5p	E2F2	-0.119583333333332	0.00146942333136967	1.25491101439873	1.34486994652531e-12	MirTarget	-1.98319503569523	9.48124426437966e-09		NA	NA	NA
hsa-miR-378a-3p	E2F2	-0.134870833333334	0.0107938354842622	1.25491101439873	1.34486994652531e-12	MirTarget	-1.4052770101504	1.10835996851322e-08		NA	NA	NA